Home
About Hyperway
Company Profile
Corporate Culture
Development History
Honors & Certifications
Management Team
Advisory Board
R&D
Pipeline
Innovation Platform
Pipeline Flagship Under Development
Collaboration
Hyperway News
Hyperway News
Contact US
Contact
Online Message
中
En
x
Search
Hyperway News
Hyperway News
Hyperway News
>
2024-10-24
Analgesic breakthrough: Hyperway Pharma's Nav1.8 inhibitor HBW-004285 enters Phase II
View more
2024-09-16
HBW-3210 demonstrates remarkable efficacy in treating brain tumors in clinical studies
View more
«
1
2
»
